111 related articles for article (PubMed ID: 16230497)
1. Genetic inflammatory factors predict restenosis after percutaneous coronary interventions.
Monraats PS; Pires NM; Agema WR; Zwinderman AH; Schepers A; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Frants RR; Quax PH; van Vlijmen BJ; Atsma DE; van der Laarse A; van der Wall EE; Jukema JW
Circulation; 2005 Oct; 112(16):2417-25. PubMed ID: 16230497
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention.
Monraats PS; Rana JS; Nierman MC; Pires NM; Zwinderman AH; Kastelein JJ; Kuivenhoven JA; de Maat MP; Rittersma SZ; Schepers A; Doevendans PA; de Winter RJ; Tio RA; Frants RR; Quax PH; van der Laarse A; van der Wall EE; Jukema JW
J Am Coll Cardiol; 2005 Sep; 46(6):1093-100. PubMed ID: 16168296
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention.
Monraats PS; Kurreeman FA; Pons D; Sewgobind VD; de Vries FR; Zwinderman AH; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Huizinga TW; Eefting D; Quax PH; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
Genes Immun; 2007 Jan; 8(1):44-50. PubMed ID: 17122782
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary intervention.
Monraats PS; de Vries F; de Jong LW; Pons D; Sewgobind VD; Zwinderman AH; de Maat MP; 't Hart LM; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Frants RR; van der Laarse A; van der Wall EE; Wouter Jukema J
Pharmacogenet Genomics; 2006 Oct; 16(10):747-54. PubMed ID: 17001294
[TBL] [Abstract][Full Text] [Related]
5. The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions.
Pons D; Monraats PS; de Maat MP; Pires NM; Quax PH; van Vlijmen BJ; Rosendaal FR; Zwinderman AH; Doevendans PA; Waltenberger J; de Winter RJ; Tio RA; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
Thromb Haemost; 2007 Dec; 98(6):1323-8. PubMed ID: 18064331
[TBL] [Abstract][Full Text] [Related]
6. Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions.
Rudez G; Pons D; Leebeek F; Monraats P; Schrevel M; Zwinderman A; de Winter R; Tio R; Doevendans P; Jukema W; de Maat M
Hum Mutat; 2008 Mar; 29(3):375-80. PubMed ID: 18175333
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention.
Monraats PS; Fang Y; Pons D; Pires NM; Pols HA; Zwinderman AH; de Maat MP; Doevendans PA; DeWinter RJ; Tio RA; Waltenberger J; Frants RR; Quax PH; van der Laarse A; van der Wall EE; Uitterlinden AG; Jukema JW
Expert Opin Ther Targets; 2010 Mar; 14(3):243-51. PubMed ID: 20095921
[TBL] [Abstract][Full Text] [Related]
8. p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity.
van Tiel CM; Bonta PI; Rittersma SZ; Beijk MA; Bradley EJ; Klous AM; Koch KT; Baas F; Jukema JW; Pons D; Sampietro ML; Pannekoek H; de Winter RJ; de Vries CJ
Circulation; 2009 Aug; 120(8):669-76. PubMed ID: 19667240
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention.
Beijk MA; Boekholdt SM; Rittersma SZ; Pons D; Zwinderman AH; Doevendans PA; Tio RA; Tijssen JG; Jukema JW; de Winter RJ
Pharmacogenet Genomics; 2010 Sep; 20(9):544-52. PubMed ID: 20671584
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha plays an important role in restenosis development.
Monraats PS; Pires NM; Schepers A; Agema WR; Boesten LS; de Vries MR; Zwinderman AH; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; 't Hart LM; Frants RR; Quax PH; van Vlijmen BJ; Havekes LM; van der Laarse A; van der Wall EE; Jukema JW
FASEB J; 2005 Dec; 19(14):1998-2004. PubMed ID: 16319143
[TBL] [Abstract][Full Text] [Related]
11. Genetic predictive factors in restenosis.
Monraats PS; R P Agema W; Jukema JW
Pathol Biol (Paris); 2004 May; 52(4):186-95. PubMed ID: 15145131
[TBL] [Abstract][Full Text] [Related]
12. Fractalkine receptor polymorphisms V2491 and T280M as genetic risk factors for restenosis.
Niessner A; Marculescu R; Kvakan H; Haschemi A; Endler G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
Thromb Haemost; 2005 Dec; 94(6):1251-6. PubMed ID: 16411402
[TBL] [Abstract][Full Text] [Related]
13. Genetic markers of restenosis after coronary angioplasty and after stent implantation.
Petrovic D; Peterlin B
Med Sci Monit; 2005 Apr; 11(4):RA127-35. PubMed ID: 15795709
[TBL] [Abstract][Full Text] [Related]
14. Analysis of recurrent revascularization events following percutaneous coronary intervention of diabetic patients.
Anselmino M; Delcrè S; Moretti C; Biondi-Zoccai G; Omedè P; Sciuto F; Trevi GP; Sheiban I
Minerva Cardioangiol; 2009 Apr; 57(2):151-7. PubMed ID: 19274025
[TBL] [Abstract][Full Text] [Related]
15. Genetic risk markers for post-angioplasty restenosis: what should we expect?
Green FR
Clin Sci (Lond); 2004 Jan; 106(1):1-2. PubMed ID: 12962537
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and safety of intra-coronary Beta irradiation with 144Ce/Pr for prevention of restenosis after percutaneous transluminal coronary angioplasty of in-stent restenotic lesions.
Bonvini RF; Hendiri T; Leo G; Aeby N; Noble J; Sigwart U; Verin V
Acute Card Care; 2006; 8(4):217-23. PubMed ID: 17162548
[TBL] [Abstract][Full Text] [Related]
17. Glycoprotein VI polymorphisms and outcome after percutaneous coronary interventions.
Boettiger C; Koch W; Mehilli J; Schoemig A; Kastrati A
Thromb Haemost; 2007 Apr; 97(4):673-4. PubMed ID: 17393032
[No Abstract] [Full Text] [Related]
18. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
[TBL] [Abstract][Full Text] [Related]
19. Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex disease.
Zee RY; Hoh J; Cheng S; Reynolds R; Grow MA; Silbergleit A; Walker K; Steiner L; Zangenberg G; Fernandez-Ortiz A; Macaya C; Pintor E; Fernandez-Cruz A; Ott J; Lindpainter K
Pharmacogenomics J; 2002; 2(3):197-201. PubMed ID: 12082592
[TBL] [Abstract][Full Text] [Related]
20. The interleukin 1B-511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients.
Miranda-Malpica E; Martínez-Rios MA; Fragoso JM; Delgadillo-Rodríguez H; Rodríguez-Pérez JM; González-Quesada C; Martínez-Rodríguez N; Saldaña-Mendoza A; Peña-Duque MA; Vargas-Alarcón G
Hum Immunol; 2008 Feb; 69(2):116-21. PubMed ID: 18361937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
